↓ Skip to main content

Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment Agencies

Overview of attention for article published in Journal of General Internal Medicine, July 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
4 news outlets
blogs
1 blog
twitter
24 X users
facebook
1 Facebook page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
15 Mendeley
Title
Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment Agencies
Published in
Journal of General Internal Medicine, July 2019
DOI 10.1007/s11606-019-05149-6
Pubmed ID
Authors

Alexander C. Egilman, Joshua D. Wallach, Sanket S. Dhruva, Gregg S. Gonsalves, Joseph S. Ross

X Demographics

X Demographics

The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 13%
Student > Ph. D. Student 2 13%
Professor > Associate Professor 2 13%
Researcher 2 13%
Student > Master 1 7%
Other 0 0%
Unknown 6 40%
Readers by discipline Count As %
Medicine and Dentistry 2 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Biochemistry, Genetics and Molecular Biology 1 7%
Agricultural and Biological Sciences 1 7%
Business, Management and Accounting 1 7%
Other 2 13%
Unknown 7 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 51. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2019.
All research outputs
#824,849
of 25,393,071 outputs
Outputs from Journal of General Internal Medicine
#662
of 8,180 outputs
Outputs of similar age
#17,700
of 359,303 outputs
Outputs of similar age from Journal of General Internal Medicine
#23
of 215 outputs
Altmetric has tracked 25,393,071 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,180 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,303 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 215 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.